Longeveron, Inc. (LGVN)
2.435
-0.04
(-1.81%)
USD |
NASDAQ |
Oct 12, 16:00
2.435
0.00 (0.00%)
After-Hours: 20:00
Longeveron Net Income (Quarterly) : -6.073M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.073M |
| March 31, 2026 | -4.736M |
| December 31, 2025 | -5.444M |
| September 30, 2025 | -7.221M |
| June 30, 2025 | -5.028M |
| March 31, 2025 | -5.011M |
| December 31, 2024 | -4.081M |
| September 30, 2024 | -4.419M |
| June 30, 2024 | -3.413M |
| March 31, 2024 | -4.058M |
| December 31, 2023 | -6.028M |
| September 30, 2023 | -5.106M |
| June 30, 2023 | -5.632M |
| Date | Value |
|---|---|
| March 31, 2023 | -4.647M |
| December 31, 2022 | -4.456M |
| September 30, 2022 | -5.244M |
| June 30, 2022 | -5.624M |
| March 31, 2022 | -3.51M |
| December 31, 2021 | -4.069M |
| September 30, 2021 | -4.855M |
| June 30, 2021 | -5.01M |
| March 31, 2021 | -3.111M |
| December 31, 2020 | -1.356M |
| September 30, 2020 | -0.938M |
| December 31, 2019 | -0.4737M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.287M |
| Total Expenses (Quarterly) | 6.36M |
| EPS Diluted (Quarterly) | -1.936 |
| Enterprise Value | -1.630M |
| Gross Profit Margin (Quarterly) | -13.59% |
| Profit Margin (Quarterly) | -2.12K% |
| Earnings Yield | -416.9% |
| Normalized Earnings Yield | -416.86 |